Development of a pH-responsive pegylated chitosan nanocarrier for targeted delivery of 17-AAG and synergistic therapy in HER2+ breast cancer
Crossref DOI link: https://doi.org/10.1038/s41598-025-30507-2
Published Online: 2025-12-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alipour, Samira
Aghamaali, Mahmoud Reza
Mahdavi, Atiyeh
Text and Data Mining valid from 2025-12-02
Version of Record valid from 2026-01-08
Article History
Received: 17 September 2025
Accepted: 25 November 2025
First Online: 2 December 2025
Declarations
:
: The authors declare no competing interests.